Citurgia Biochemicals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | TBA | TBA | TBA |
| Operating Expense | 0.06 | 0.05 | 0.08 |
| Net Profit | -0.12 | -0.10 | -0.14 |
| Net Profit Margin | TBA | TBA | TBA |
| Earning Per Share | 0.01 | 0.01 | -0.01 |
| EBIDTA | -0.06 | -0.04 | -0.08 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Revenue | TBA |
| Operating Expense | 0.06 |
| Net Profit | -0.12 |
| Net Profit Margin | TBA |
| Earning Per Share | 0.01 |
| EBIDTA | -0.06 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | TBA | TBA | TBA |
| Operating Expenses Annual | 0.20 | 0.25 | 0.21 |
| Operating Profit Annual | -0.20 | -0.25 | -0.21 |
| Interest Annual | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.23 | 0.23 | 0.23 |
| Net Profit Annual | -0.42 | -0.48 | -0.44 |
| Tax Annual | TBA | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | TBA |
| Operating Expenses Annual | 0.20 |
| Operating Profit Annual | -0.20 |
| Interest Annual | 0.00 |
| Depreciation | 0.23 |
| Net Profit Annual | -0.42 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.10 | 0.08 | 0.05 |
| Cash Flow from Operations | -0.12 | -0.14 | -0.07 |
| Cash Flow from Investing | 0.07 | -0.05 | 0.04 |
| Cash Flow from Financing | 0.06 | 0.22 | 0.06 |
| Cash Flow at the End | 0.12 | 0.10 | 0.08 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.10 |
| Cash Flow from Operations | -0.12 |
| Cash Flow from Investing | 0.07 |
| Cash Flow from Financing | 0.06 |
| Cash Flow at the End | 0.12 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | TBA | TBA | TBA |
| PBIT Margin (%) | TBA | TBA | TBA |
| PBT Margin (%) | TBA | TBA | TBA |
| Net PROFIT Margin (%) | TBA | TBA | TBA |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | TBA | TBA | TBA |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | TBA | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | TBA |
| PBIT Margin (%) | TBA |
| PBT Margin (%) | TBA |
| Net PROFIT Margin (%) | TBA |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | TBA |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 0.62 | 0.85 | 1.07 |
| Total Current Assets Annual | 8.32 | 8.30 | 8.28 |
| Non Current Assets Annual | 2.45 | 2.74 | 2.92 |
| Total Shareholders Funds Annual | -6.99 | -6.57 | -6.09 |
| Total Assets Annual | 10.76 | 11.04 | 11.19 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 0.62 |
| Total Current Assets Annual | 8.32 |
| Non Current Assets Annual | 2.45 |
| Total Shareholders Funds Annual | -6.99 |
| Total Assets Annual | 10.76 |
No Data Availabe
